As drug pricing programs grow increasingly complex & opaque, manufacturers face mounting risks to both compliance and revenue. The intersection of the 340B program, the Medicaid Drug Rebate Program (MDRP), Commercial, and the upcoming Maximum Fair Price (MFP) regulations has intensified the challenge of managing compliance, especially for specialty drug manufacturers.
In this evolving landscape, transparency is no longer optional–it’s a critical necessity for ensuring compliance, optimizing pricing strategies, and protecting revenue. Without a unified, end-to-end drug discount management platform, the overlap can lead to significant revenue leakage, impacting both profitability and the ability to provide affordable therapies to patients.
Join us in exploring how you as a manufacturer can empower your company with the help of Kalderos, the leading expert in the 340B and overall drug discount space. In this webinar, we’ll break down the lack of transparency, the growing risk landscape, and show how manufacturers can simplify the complexities of murky compliance, prevent duplicate discounts, and better protect their gross-to-net (GTN) performance. You’ll also get a close look at Truzo, the first end-to-end drug discount management platform. We’ll also feature our Truzo Commercial solution and explore streamlining PBM contract compliance & analysis.
Key Takeaways:
- Learn how transparent data can help simplify complex drug program compliance
- Understand how overlapping discount programs impact therapies, including specialty drug portfolios
- Learn actionable strategies to reduce duplicate discounts and prevent revenue leakage
- Explore how Truzo provides a holistic, end-to-end view across all drug discount programs to stop duplicate discounts at the source
- Discover how to regain control of your commercial PBM contracts via analytics
- See how Truzo integrates with third-party vendors to enhance your existing ecosystem
The need for transparency in drug discount management is long overdue. Don’t miss this opportunity to gain actionable insights, reduce inefficiencies, and protect your organization’s bottom line.
